Determination of CD4 lymphocyte percentages using a new simplified and affordable no lyse flow cytometric protocol: A pilot study

LaboratoriumsMedizin

Volumn 32, Issue 3, 2008, Pages 182-189

  Greve, Burkhard ^a   Cassens, Uwe ^a,b   Baumann, Claudia ^a,b   Sibrowski, Walter ^a,b   Kuling, Gudrun ^c   Szabados, Florian ^d   Schlenke, Peter ^e   Reichelt, Doris ^a   Gebauer, Wolfgang ^f   Göhde, Wolfgang ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b KLINIKUM DORTMUND   (Germany)

^c Section of Pathology   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f KLINIKUM OLDENBURG   (Germany)

Author keywords

CD4; Flow cytometry; HIV; Paediatric

Indexed keywords

ARTICLE; CD4 LYMPHOCYTE COUNT; CD4 LYMPHOCYTE PERCENTAGE; CHILD; CLINICAL ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; PILOT STUDY; STATISTICAL ANALYSIS;

EID: 44949117762     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/JLM.2008.026     Document Type: Article

References (30)

1. UNAIDS, WHO. AIDS epidemic update. Geneva: World Health Organization 2004:1-80
2. Sibanda EN, Stanczuk G, Kasolo F. HIV/AIDS in Central Africa: pathogenesis, immunological and medical issues. Int Arch Allergy Immunol 2003;132:183-95.
3. van Niekerk AA. Moral and social complexities of AIDS in Africa. J Med Philos 2002;27:143-62.
4. Foster S, Buve A. Benefits of HIV screening of blood transfusions in Zambia. Lancet 1995;346:225-7.
5. Sidley P. Sharp rise in deaths in South Africa is largely due to AIDS. Br Med J 2005;330:438.
6. Villamor E, Misegades L, Fataki MR, Mbise RL, Fawzi WW. Child mortality in relation to HIV infection, nutritional status, and socio-economic background. Int J Epidemiol 2005;34:61-8.
7. Staton DM, Harding MH. Protecting child health worldwide. Implementation is the biggest challenge slowing efforts to reduce childhood morbidity and mortality in developing countries. Pediatr Ann 2004;33:647-55.
8. De Rossi A. Virological and immunological response to antiretroviral therapy in HIV-1 infected children: genotypic and phenotypic assays in monitoring virological failure. New Microbiol 2004;27:45-50.
9. Zijenah LS, Katzenstein DA, Nathoo KJ, Rusakaniko S, Tobaiwa O, Gwanzura C, et al. T lymphocytes among HIV-infected and -uninfected infants: CD4/CD8 ratio as a potential tool in diagnosis of infection in infants under the age of 2 years. J Transl Med 2005;3:6.
10. Tovo PA, de Martino M, Gabiano C, Cappello N, D'Elia R, Loy A, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian register for HIV infections in children. Lancet 1992;339:1249-53.
11. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. 2008. http://aidsinfo.nih.gov/contentfiles/ pediatricGuidelines.pdf. 2004.
12. Group HPPMCS. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet 2003;362:1605-11.
13. Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002. IAPAC Mon 2002;8:168-75.
14. 3. J Infect Dis 2005;192:950-7.
15. Goicoechea M, Haubrich R. CD4 lymphoctye percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: an old debate revisited. J Infect Dis 2005;192:945-7.
16. Diagbouga S, Durand G, Sanou PT, Dahourou H, Ledru E. Evaluation of a quantitative determination of CD4 and CD8 molecules as an alternative to CD4+ and CD8+ T lymphocyte counts in Africans. Trop Med Int Health 1999;4:79-84.
17. Johnson D, Hirschkorn D, Busch MP. Evaluation of four alternative methodologies for determination of absolute CD4+ lymphocyte counts. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:522-30.
18. Janossy G, Jani I, Gohde W. Affordable CD4(+) T-cell counts on 'single-platform' flow cytometers I. Primary CD4 gating. Br J Haematol 2000;111:1198-208.
19. Landay A, Ho JL, Hom D, Russell T, Zwerner R, Minuty JG, et al. A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS 1993;7:1565-8.
20. Sherman GG, Galpin JS, Patel JM, Mendelow BV, Glencross DK. CD4+ T cell enumeration in HIV infection with limited resources. J Immunol Methods 1999;222:209-17.
21. Mandy F, Nicholson J, Autran B, Janossy G. T-cell subset counting and the fight against AIDS: reflections over a 20-year struggle. Cytometry 2002;50:39-45.
22. Lynen L, Teav S, Vereecken C, De Munter P, An S, Jacques G, et al. Validation of primary CD4 gating as an affordable strategy for absolute CD4 counting in Cambodia. J Acquir Immune Defic Syndr 2006;43:179-85.
23. Greve B, Cassens U, Westerberg C, Göhde W jun, Sibrowski W, Reichelt D, et al. A new no-lyse, no-wash flow-cytometric method for the determination of CD4 T cells in blood samples. Transfus Med Hemother 2003;30:8-13.
24. Cassens U, Gohde W, Kuling G, Groning A, Schlenke P, Lehman LG, et al. Simplified volumetric flow cytometry allows feasible and accurate determination of CD4 T lymphocytes in immunodeficient patients worldwide. Antivir Ther 2004;9:395-405.
25. Zijenah LS, Kadzirange G, Madzime S, Borok M, Mudiwa C, Tobaiwa O, et al. Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited setting. J Transl Med 2006;4:33.
26. Dieye TN, Vereecken C, Diallo AA, Ondoa P, Diaw PA, Camara M, et al. Absolute CD4 T-cell counting in resource-poor settings: direct volumetric measurements versus bead-based clinical flow cytometry instruments. J Acquir Immune Defic Syndr 2005;39:32-7.
27. Imade GE, Badung B, Pam S, Agbaji O, Egah D, Sagay AS, et al. Comparison of a new, affordable flow cytometric method and the manual magnetic bead technique for CD4 T-lymphocyte counting in a northern Nigerian setting. Clin Diagn Lab Immunol 2005;12:224-7.
28. Alvarez-Larran A, Jover L, Marin P, Petriz J. A multicolor, no-lyse no-wash assay for the absolute counting of CD34+ cells by flow cytometry. Cytometry 2002;50:249-53.
29. Cassens U, Greve B, Tapernon K, Nave B, Severin E, Sibrowski W, et al. A novel true volumetric method for the determination of residual leucocytes in blood components. Vox Sang 2002;82:198-206.
30. Jou JM, Pastor C, Aymerich M, Villamor N, Reverter JC, Brugues RM, et al. [Evaluation of the Sysmex NE-8000 analyzer according to the norms of the International Committee for Standardization in Hematology]. Sangre (Barc) 1991;36:387-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list_uids=1816636.